Interferon alfa
Sponsors
National Center for Research Resources (NCRR), H. Lee Moffitt Cancer Center and Research Institute, SWOG Cancer Research Network, Pfizer, Centre Leon Berard
Conditions
CancerCarcinoma, Renal CellChronic Hepatitis bCovid19HBVHepatitis CKidney NeoplasmsLeukemia
Phase 1
Phase 2
Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI
CompletedNCT00363649
Start: 2006-09-30End: 2017-09-30Updated: 2018-11-13
Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin
CompletedNCT07671495
Start: 2014-01-01End: 2018-12-01Updated: 2026-06-30
Phase 3
Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C
CompletedNCT00004804
Start: 1993-08-31Target: 57Updated: 2005-06-24
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
CompletedNCT00006237
Start: 2000-08-31End: 2012-07-31Updated: 2015-03-25
Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
CompletedNCT00065468
Start: 2003-07-31End: 2011-03-31Updated: 2012-10-25
Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis
CompletedNCT00291369
Start: 1999-12-31End: 2005-02-28Target: 456Updated: 2006-02-16
COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;
CompletedNCT04534725
Start: 2020-12-17End: 2023-04-19Updated: 2023-08-24